DSM-Firmenich releases 2025 sustainability report (€73.46, 0.00)
DSM-Firmenich achieves FDA approval for PARSOL shield (€70.04, -1.56)
Energy, food/beverage, banks and defensive sectors outperform; cyclicals the top laggards:
European chemicals sector faces fresh headwinds despite partial recovery:
StreetAccount Summary - Trading higher/lower: EU mid-morning
DSM-Firmenich announced the listing of its ordinary shares on SIX Swiss Exchange (€67.72, 0.00)
Powered by FactSet Research Systems Inc.